Trial comparisons

curl "https://conductscience.org/api/comparisons/v1?page=105"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=105

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT05576051-8923d4e6",
        "title": "All TNFi Initiators Combination vs Tofacitinib Initiators Combination: Number of Participants With mACR20 at 6 Months for Tofacitinib Combination With MTX vs TNFi Combination With MTX",
        "summary": "1224 of 4013 against 19 of 90; risk difference 9.4 points, 95% interval -0.2 to 16.7; NCT05576051, To Estimate the Efficacy of Treatment With TNFi as Monotherapy or Combination Therapy With MTX and Compare and Contrast Efficacy With Tofacitinib as Monotherapy and Combination Therapy in a Real World Setting.",
        "record": "/library/comparisons/NCT05576051-8923d4e6",
        "nct_id": "NCT05576051",
        "kind": "outcome",
        "participants": 4103,
        "risk_difference": {
          "value": 0.09389761054351134,
          "lower": -0.0023704847397606754,
          "upper": 0.16692187106859988
        },
        "group_1": "1,224 of 4,013",
        "group_2": "19 of 90",
        "difference": "9.4 points",
        "interval": "-0.2 to 16.7",
        "trial_title": "To Estimate the Efficacy of Treatment With TNFi as Monotherapy or Combination Therapy With MTX and Compare and Contrast Efficacy With Tofacitinib as Monotherapy and Combination Therapy in a Real World Setting."
      },
      {
        "id": "NCT00141102-278f4495",
        "title": "Celecoxib vs Oral Diclofenac Plus Omeprazole: Number of Subjects Hospitalized in Last 6 Months at the Post Trial Interview",
        "summary": "82 of 2047 against 79 of 2048; risk difference 0.1 points, 95% interval -1.1 to 1.4; NCT00141102, Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis",
        "record": "/library/comparisons/NCT00141102-278f4495",
        "nct_id": "NCT00141102",
        "kind": "outcome",
        "participants": 4095,
        "risk_difference": {
          "value": 0.0014844036242061542,
          "lower": -0.010524506321263751,
          "upper": 0.013511999897525575
        },
        "group_1": "82 of 2,047",
        "group_2": "79 of 2,048",
        "difference": "0.1 points",
        "interval": "-1.1 to 1.4",
        "trial_title": "Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=106",
  "request_id": "vYsdORSFh8Xar2hL"
}